Literature DB >> 6415784

Mechanisms of mucosal invasion by pathogenic Neisseria.

Z A McGee, D S Stephens, L H Hoffman, W F Schlech, R G Horn.   

Abstract

Neisseria gonorrhoeae are transported across the mucosa of human fallopian tubes in organ culture by mucosal cells. The steps in this process are (1) attachment of gonococci to microvilli of nonciliated cells, (2) phagocytosis of gonococci by these cells, (3) transport of phagocytic vacuoles containing gonococci to the base of the cell, and (4) exocytosis of gonococci with phagocytic vacuoles into the subepithelial tissues. In vivo gonococci in the subepithelial tissues may cause extensive local disease (e.g., salpingitis) or invade blood vessels to cause disseminated disease. Preliminary studies of human nasopharyngeal tissue in organ culture infected with Neisseria meningitidis indicate that meningococci attach to microvilli of nonciliated cells and are phagocytized by these cells. They subsequently appear in subepithelial tissues, but the route they take is not yet certain. These observations suggest that the mechanisms of attachment to and penetration of fallopian tube and nasopharyngeal mucosa by N. gonorrhoeae and N. meningitidis are similar or possibly identical.

Entities:  

Mesh:

Year:  1983        PMID: 6415784     DOI: 10.1093/clinids/5.supplement_4.s708

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  44 in total

1.  Insertion mutations in pilE differentially alter gonococcal pilin antigenic variation.

Authors:  B Howell-Adams; H S Seifert
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Neisseria gonorrhoeae porin modifies the oxidative burst of human professional phagocytes.

Authors:  D R Lorenzen; D Günther; J Pandit; T Rudel; E Brandt; T F Meyer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Effects of the immunoglobulin A1 protease on Neisseria gonorrhoeae trafficking across polarized T84 epithelial monolayers.

Authors:  S Hopper; B Vasquez; A Merz; S Clary; J S Wilbur; M So
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.

Authors:  J P Phanucharas; G L Gorby
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Experimental infection of native human ureteral tissue with Neisseria gonorrhoeae: adhesion, invasion, intracellular fate, exocytosis, and passage through a stratified epithelium.

Authors:  I M Mosleh; H J Boxberger; M J Sessler; T F Meyer
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Distinct mechanisms of internalization of Neisseria gonorrhoeae by members of the CEACAM receptor family involving Rac1- and Cdc42-dependent and -independent pathways.

Authors:  Oliver Billker; Andreas Popp; Volker Brinkmann; Gerald Wenig; Jutta Schneider; Emmanuelle Caron; Thomas F Meyer
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 7.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 8.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Quantification of bacterial internalization by host cells using a beta-lactamase reporter strain: Neisseria gonorrhoeae invasion into cervical epithelial cells requires bacterial viability.

Authors:  Samuel E Bish; Wenxia Song; Daniel C Stein
Journal:  Microbes Infect       Date:  2008-07-17       Impact factor: 2.700

10.  Stimulation of human neutrophil oxidative metabolism by nonopsonized Neisseria gonorrhoeae.

Authors:  F L Naids; R F Rest
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.